News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
ImmuPharma plc Positive on 2008 Progress
May 12, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LONDON (Thomson Financial) - ImmuPharma Plc. posted a bullish update alongside its 2007 results, saying it expects to report further progress in 2008, principally the results of its Phase IIb trial for its key drug candidate for lupus.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
Business
11 Startups Selected for National Life Sciences Accelerator Program
April 1, 2026
·
2 min read
·
Angela Gabriel
Podcast
Biopharma M&A Heats Up, Rare Diseases Win Three Approvals, Wave Crashes
April 1, 2026
·
1 min read
·
Heather McKenzie
Funding
Ambrosia Eyes Next-Generation Small Molecule GLP-1s With $100M Series B
April 1, 2026
·
2 min read
·
Tristan Manalac
Company closure
IO Shuts Down Following Regulatory Roadblocks
April 1, 2026
·
2 min read
·
Tristan Manalac
